Table 4.

Acute effects of benzo[a]pyrene on GST activity (mean ± SD, n = 10).

Group	Time	Liver	Lung	Kidney	Stomach	Brain
Control	24	78.23 ± 12.39	64.68 ± 9.12	54.75 ± 6.84	62.65 ± 9.51	56.89 ± 4.62
12.5 mg/kg	24	98.49 ± 12.57b	85.11 ± 8.26c	75.72 ± 6.87c	88.04 ± 9.33c	76.13 ± 4.08c
25 mg/kg	24	95.16 ± 11.31b	80.60 ± 5.95c	72.65 ± 7.21c	86.64 ± 8.19c	72.74 ± 6.45c
50 mg/kg	24	92.88 ± 8.01b	78.80 ± 7.26b	68.33 ± 9.81b	84.64 ± 8.29c	66.36 ± 3.45c
100 mg/kg	24	89.17 ± 7.22a	76.12 ± 7.33b	65.56 ± 7.24b	81.42 ± 7.32c	64.62 ± 4.52b
Control	48	77.52 ± 11.42	62.74 ± 9.24	52.25 ± 6.66	60.74 ± 9.67	55.81 ± 4.75
12.5 mg/kg	48	94.53 ± 13.13b	78.02 ± 8.26b	73.97 ± 4.91c	85.02 ± 9.34c	72.29 ± 5.59c
25 mg/kg	48	92.61 ± 9.31b	76.12 ± 5.59b	70.45 ± 5.95c	84.09 ± 8.66c	68.81 ± 4.01c
50 mg/kg	48	90.35 ± 9.10a	75.88 ± 6.19b	65.80 ± 6.94c	82.22 ± 5.77c	62.78 ± 4.84b
100 mg/kg	48	85.56 ± 9.04	74.76 ± 7.02b	62.25 ± 7.14b	80.06 ± 6.13c	60.74 ± 4.96a
Control	72	76.34 ± 11.63	62.12 ± 9.36	50.85 ± 6.81	60.13 ± 9.74	55.12 ± 4.55
12.5 mg/kg	72	91.77 ± 11.23b	71.10 ± 6.63a	70.98 ± 6.44c	80.41 ± 8.89c	66.34 ± 5.73c
25 mg/kg	72	89.95 ± 11.88a	69.44 ± 6.05	68.76 ± 7.18c	81.93 ± 8.75c	64.04 ± 4.71c
50 mg/kg	72	87.74 ± 7.76a	68.85 ± 6.46	62.21 ± 8.59b	81.39 ± 5.14c	60.43 ± 3.95a
100 mg/kg	72	81.28 ± 7.86	65.52 ± 7.12	58.11 ± 7.52a	78.24 ± 6.29c	58.36 ± 4.58

^aP < 0.05.

^bP < 0.01.

^cP < 0.001 between the corresponding control and B[a]P treatment groups, respectively.